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Summary
CD34+ human marrow cells not expressing T cell-, B cell-, and myeloid cell-associated antigens
(TBM-) were cloned by two-color cell sorting into culture wells containing irradiated marrow
stromal cells. After 4 wk of culture, 3.7 t 2.1% of these cells generated colony-forming cells
(CFC), with each of these cells generating 6.3 ± 5.3 CFC. This was not due to the 0.5 ±
0.5% CFC present in the purified CD34+ TBM- cells, as <1% of CFC persist in these cultures.
This is the first demonstration that single immature precursor cells in human long-term cultures
generate multiple CFC progeny. The immature nature of these clonable CD34' TBM-
precursors suggests their candidate status as human hematopoietic stem cells.
H
ematopoiesis is maintained in vivo by multipotential stem
cells (1-3). In humans, the characterization of these rare
cells has been elusive, due to an inability to purify them and
the absence of a suitable in vitro clonal assay to study their
potential. Precursors of myeloid colony-forming cells (CFC)
can be distinguished from their more mature CFC progeny
based on surface antigen expression and light scatter proper-
ties (4-6). While these cellsdo not form colonies in soft agar
in the presence of most known growth factors, they produce
CFC after culture with marrow stromal cells (MSC).
Ifthese precursors of CFC are highly immature cells, then
single cells should give rise to multiple CFC in vitro. In pre-
viously reported studies, the lack ofa clonal assay for precursors
of CFC in long-term culture precluded this conclusion. The
absolute number of detectable CFC did not exceed the abso-
lute number ofcells placed in the cultures (4-6). In the present
studies, based on direct cloning of single cells by two-color
FACS, we identified a minor subpopulation of CD34+
marrow cells (<l% of CD34+ cells) in which at least 1-7%
of cells were precursors for more than one granulocyte/mac-
rophage (GM)-CFU.
Materials and Methods
Antibody Pwparation and Purification.
￿
Antibodies 35.1 (anti-CD2)
(7), G3-7 (anti-CD7) (7), 24.1 (anti-CD10) (7), 60.3 (anti-CD18)
(7), 4119 (anti-CD19) (8), and F13 (anti-CD36) (7) were used as
1 :1,000 dilutions of ascites fluids. Isotype controls were 31A (9)
(IgG, anti-mouse Thy-1.1) and H12C12 (5) (IgM, anti-mouse Thy-
1.2). IgM antibodies 12-8 (anti-CD34) (10) and H12C12, and IgG
antibodies 1F5 (anti-CD20) (7), p67-6 (anti-CD33) (5), and 31A
were purified as described (5, 11), and used at 25 ug/ml for IgMs
and 5 ug/ml for IgGs (based on titers). 7B9 identifies a novel an-
tigen present on GM-CFU, erythroid (E)-BFU, E-CFU, and MIX-
CFU (Bernstein et al., manuscript in preparation).
Separation ofMarrow Cells.
￿
Marrow samples obtained after in-
formed consent were separated byFicoll-Hypaque density centrifu-
gation (4, 5). Cellswere labeled simultaneously with the IgG anti-
bodies F13, 35.1, G3-7, 24.1, 4119, 1F5, 60.3, p67-6, and 7B9
(ABYMIX) using previouslydescribed methods (5), and were then
mixed with goat anti-mouse IgG antibody-conjugated magnetic
particles (five particles/cell; Exps. 2-5) (Advanced Magnetics, Cam-
bridge, MA), or with a 1 :80 dilution of biotin-conjugated goat
anti-mouse IgG antisera (y chain specific; Southern Biotechnology
Associates, Birmingham, AL), washed twice, and then mixed with
streptavidin-conjugated magnetic particles (five particles/cell; Exp.
1) (Advanced Magnetics). The cell-particle mixtures were gently
rocked for 20 min at 4°C. Cells bound to the particles were re-
moved from suspensionusingmagnets (Biomag Separator; Advanced
Magnetics). Unbound cells were stained using two-color indirect
immunofluorescent antibody staining techniques with 12-8 or the
control antibody H12C12, and to detect residual IgGbearing cells,
as described (5). Unseparated cells labeled with: (a) H12C12 and
31A; (b) 12-8 and 31A; (c) H12C12 and ABYMIX; and (d) 12-8
and ABYMIX served as controls (5). Cells were separated using
a modified FACS-II equipped with a modified single-cell deposi-
tion unit (Becton Dickinson & Co., Mountain View, CA), calibrated
as described (5). To verify the sorting of single events, we sorted
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ized each well. Of288 wells cloned in two experiments, 96% con-
tained single beads, 4% contained no beads, and <0.35% contained
two beads.
Colonpforming Assays.
￿
Thesewere performed aspreviouslydescribed
in soft agar with human placental conditioned medium (HPCM) and
purified human urinary erythropoietin (EPO) (Terry Fox Cancer Re-
search Center, Vancouver, Canada). In some studies, assays were per-
formed by depositingsingle cells in microtiter wells containing50 pl
of liquid medium containing HPCM and EPO. 50 /Al of agar con-
taining medium was then added to each well and allowed to gel.
Liquid Cultures in Microtiter Wells.
￿
MSC layers were generated in
75-cm' tissue culture flasks, transferred to wells of microtiter
plates, and were irradiated (1,200 cGy; 80 cGy/min) as previously
described (5) . Marrow cells were cultured in the microtiter wells
containing irradiated MSC (4, 5) for 7 d at 37°C, after which time
cultures were maintained at 33'C and fed weekly (4). For CFC
assays, the entire contents of each culture well,including the MSC,
were removed by vigorous pipetting and scraping.
Results
Single CD34' TBM- Marrow Cells in Long-Term Culture.
Marrow cells expressing T cell, B cell, or myeloid cell antigens
(TBM' cells) were labeled with mAbs to the CD2, CD7,
CD10, CD18, CD19, CD20, CD33, CD36, and 7B9 an-
tigens. By flow cytometry, 2.2 ± 1.1% of all marrow cells,
and <1% of all CD34+ marrow cells, did not detectably ex-
press these antigens. Labeled cells were removed from sus-
pension by two cycles of immunoadsorption to magnetic par-
ticles (see Materials and Methods) . After adsorption, 3.6 ±
2.9% (range, 9-0.2%) of the marrow cells remained. These
unadsorbed cells were labeled with the anti-CD34 antibody
12-8 (IgM) and stained to detect residual TBM' (IgG') cells
not depleted by adsorption. Of the unadsorbed cells, CD34+
TBM- cells with low right angle light scattering properties
identifiedby two-color FACS represented 0.8 ± 0.9% (range,
2.2-0.06%) of the cells. Based on the frequency of CD34+
TBM` cells detectable in these unadsorbed populations, we
estimated that the CD34+ TBM- cells represented 8.9 ±
6.6 x 10-5 cells in unseparated marrow.
Table 1.
￿
Cloning of CD34' TBM- Precursors of Myeloid CFC
Wells with CFC (wells assayed)
Numbers in parentheses are percents.
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Clonal liquid cultures
Week 2
￿
Week 4
3.0 ± 2.3
Single CD34' TBM- cells were deposited by the cell
sorter directly into microtiter wells containing irradiatedMSC,
and were also collected nonclonally for culture in soft agar
and in microwells over MSC. In five experiments, a mean
of 3.7 ± 2.1% of cloned CD34' TBM- cells generated
CFC after 4 wk of culture, whereas after 2 wk of culture,
only 0.9 ± 0.9% of these cells generated CFC (Table 1).
The finding that most positive wells contained more than
three CFC (0.5% of cloned cells at 2 wk, 3.1% of cloned
cells at 4 wk) provided evidence for at leastlimited self-renewal
by these individual cells or their immediate progeny. The
colonies detected were often associated with stromal cells,
but not frequently clustered together, and varied in size from
100 to >1,000 cells, as estimated by counting in the plates.
Based on the percent positive wells, the calculated frequency
of precursors of CFC in unseparated marrow was 1.4 ± 0.4
x 10-6.
In two experiments, the agar containing colonies derived
from CD34` TBM- cells were fixed, dried on glass slides,
and stained with benzidine. One colony was identified that
contained benzidine-positive erythroblasts, as well as granu-
locytes and monocytes, otherwise, only GM-CFU were de-
tected. Both E-BFU and GM-CFU were detected at 4 wk
in cultures initiated with >100 CD34' TBM" cells in these
experiments, though E-BFU were 5-10-fold less frequent than
GM-CFU in these cultures.
Single CD34+ CD33+ 7B9' Cells in Long-Term Culture.
Immediately after sorting, 0.5 ± 0.5% of CD34' TBM-
cells formed colonies detectable in soft agar. Thus, it was pos-
sible that CFC detected after 2 and 4 wk of liquid culture
were due to maintenance and expansion ofresidual CFC. We
therefore determined the ability of single CFC to be main-
tained and self-renew in this culture system. CFC were en-
riched from marrow by selecting CD34' cells that were also
CD33+ and 7B9+ (Table 2). Single cells were deposited in
microtiter wells, to assay for colony formation, and into mi-
crotiter wells containingirradiated MSC. On direct culture
of single CD34' CD33+ 7B9+ cells in two experiments, 52
and 47% formed single colonies or clusters (Table 2). None
CFC/well
Human Hematopoietic Precursors in Long-Term Culture
Direct cultures
(CFC/No. cells assayed)
7 ± 3
￿
0/300 (0)
ND
￿
15/2,000 (0.8)
2 ± 1
￿
14/1,000 (1.4)
7 ± 6
￿
1/500 (0.2)
6
￿
4/1,125 (0.4)
6 .3 ± 5 .3
￿
0.5 ± 0.5
Exp. Week 2 Week 4
1 0/96 (0) 4/88 (4.5)
2 1/136 (0.7) ND
3 2/113 (1.8) 2/75 (2.7)
4 3/134 (2.3) 9/134 (6.7)
5 0/90(0) 1/96 (1 .0)
X ± SD 0.9 ± 0.9 3.7 ± 2.1Discussion
of the wells contained more than a single colony, further
confirming the single-cell origin of cultures obtained by di-
rect cloning. Of 361 wells containing MSC that were inocu-
lated with single cells and cultured for 2 and 4 wk, only two
wells were found that contained single small nonerythroid
colonies. These results demonstrate that the multiple CFC
detected in the cultures of CD34+ TBM- cells most likely
arose from immature precursor cells and not from classical
growth factor-responsive CFC.
Recent data have suggested that the CD34 antigen is ex-
pressed by marrow cells that can reconstitute hematopoiesis
in vivo in both humans and nonhuman primates (12, 13).
In clinical trials of bone marrow transplantation, stem cells
that reconstitute in vivo lymphohematopoiesis have not been
detectably depleted by using mAbs to T cell- (CD2, CD7),
B cell- (CD10, CD19, CD20), or myeloid cell- (CD33) as-
sociated antigens to remove malignant and normal lympho-
hematopoietic cells from marrow (14-20, and unpublished
observations). Significantly, depleting marrow of CD33+
cells eliminates most unipotent and multipotent CFC (4, 5,
21). We have shown previously that CD34+ CD33- marrow
cells, representing <1% of marrow-nucleated cells, contain
immature precursor cells that, after culture over MSC, gain
See Materials and Methods for details. Numbers in parentheses are percents.
Cells assayed in soft agar immediately after sorting.
# Nine GM-CFU, 24 M-CFU, 11 E-BFU; two clusters.
S 50 GM-CFU, 53 M-CFU, 15 E-BFU, three CFU-MIX; 16 clusters.
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the capacity to form CD33+ unipotent and multipotent my-
eloid colonies in the presence of hematopoietic growth factors
(4, 5). However, these studies did not determine if single cells
were precursors for multiple or single CFC, as the totalnumber
of CFC detectable in the cultures was always less than the
number of cells used to initiate the cultures.
In the present studies, we have identified a minor popula-
tion of CD34+ TBM- cells in human marrow that are en-
riched for clonable precursors that generate multiple CFC
when cultured with MSC. These isolated precursors have a
frequency of -1.4 ± 0.4 x 10-6 cells in marrow if the
cloning efficiency was 100%, or 1-2 x 10-5 cells if the
cloning efficiency was 10%, similar to that found for stem
cells in murine studies by Weissman and colleagues (22). The
generation of multiple CFC from single CD34+ TBM" cells
demonstrating self-renewal and differentiation, and the length
ofculture required to generate CFC progeny, are compatible
with models of hematopoietic stem cells in vivo (23, 24).
The approaches outlined in this report present the possi-
bility of assessing factors that influence self-renewal, prolifer-
ation, and maturation of single highly immature hemato-
poietic precursors, as well as the biologic heterogeneity of
this population. Highly enriched stem cell populations may
be suitable targets for inserting genes by either retroviralvectors
or by microinjection. Formal evidence of the stem cell nature
of these isolated cells will require in vivo studies, possibly
using immunodeficient mouse models (25, 26).
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Table 2. Cloning of CD34+ CD33+ 7B9+ Myeloid
Clonal
Colony-forming Cells
liquid cultures
Wells with CFC (wells assayed) CFC/Well
Direct cultures"
Exp. Week 2 Week 4 Week 2 Week 4 (CFC/No. cells assayed)
1 0/45 (0) 0/48 (0) 0 0 44/86 (51)#
2 ND 2/268 (0.7) ND 1 121/288 (42)S
X{ ± SD 0% 0.4% ND 1 47%References
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